Wilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells
- 4 February 2009
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 45 (5), 874-880
- https://doi.org/10.1016/j.ejca.2008.12.030
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic CancerClinical Cancer Research, 2008
- Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteinsCancer Letters, 2008
- Epidemiology and risk factors for pancreatic cancerBest Practice & Research Clinical Gastroenterology, 2006
- Curcumin inhibits WT1 gene expression in human leukemic K562 cells1Acta Pharmacologica Sinica, 2006
- Inhibitory effect of curcumin onWT1 gene expression in patient leukemic cellsArchives of Pharmacal Research, 2006
- Pancreatic carcinomaThe Lancet, 1997
- High affinity binding sites for the Wilms’ tumour suppressor protein WT1Nucleic Acids Research, 1995
- Binding of the Wilms' Tumor Locus Zinc Finger Protein to the EGR-1 Consensus SequenceScience, 1990
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990